Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients with Advanced Non-Small Cell Lung Cancer: Results from a Phase 2 Pivotal Study

Q. Zhou, X. Meng,L. Sun,D. Huang, N. Yang, Y. Yu,M. Zhao,W. Zhuang, Y. Hu, Y. Pan, M. Sun,J. Shan,R-H. Guo,Q. Chu, C. Xu, J. Lin, J. Huang, M. Huang, Y. Shen,Y-L. Wu

Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer（2024）

引用 0|浏览33

暂无评分

关键词

IBI351,GFH925,NSCLC,KRAS G12C,Chinese patients,Pivotal study

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要